When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - ImmunoGen's mirvetuximab shows treatment benefit in FR?-positive ovarian cancer
ImmunoGen Inc.
ImmunoGen (NASDAQ:IMGN)announces final data from the FORWARD II triplet cohort evaluating mirvetuximab soravtansine in combination with carboplatin and Avastin (bevacizumab) in patients with folate receptor alpha (FR?)-positive recurrent, platinum-sensitive ovarian cancer at the European Society for Medical Oncology (ESMO) 2020 Virtual Congress.
More news on: ImmunoGen, Inc., Healthcare stocks news,